Trevi Therapeutics (TRVI) Current Leases (2019 - 2026)
Trevi Therapeutics' (TRVI) quarterly Current Leases came in at $318000.0 in Q1 2026, up 15.22% year-on-year from $276000.0 in Q1 2025, and up 3.58% quarter-over-quarter from $307000.0 in Q4 2025.
Trevi Therapeutics (TRVI) Current Leases (2019 - 2026) Analysis & Trends
Trevi Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $318000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 15.22% year-over-year to $318000.0 in Q1 2026; TTM through Mar 2026 was $318000.0, a 15.22% increase from a year earlier, with the FY2025 full-year figure at $307000.0, up 890.32% from the prior year.
- Current Leases climbed to $318000.0 in Q1 2026 per TRVI's latest filing, from $307000.0 in the prior quarter.
- Across five years, Current Leases topped out at $318000.0 in Q1 2026 and bottomed at $25000.0 in Q4 2022.
- The 5-year median for Current Leases is $140500.0 (2023), against an average of $159937.5.
- Across the five-year window, Current Leases sank 83.15% in 2024 and surged 890.32% in 2025, its largest moves.
- Year by year, Current Leases stood at $25000.0 in 2022, then jumped by 636.0% to $184000.0 in 2023, then sank by 83.15% to $31000.0 in 2024, then jumped by 890.32% to $307000.0 in 2025, then gained by 3.58% to $318000.0 in 2026.
- Per Business Quant, the three latest TRVI Current Leases figures stand at $318000.0 (Q1 2026), $307000.0 (Q4 2025), and $296000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Trevi Therapeutics | 2.54 Bn | 2.54 Bn | - | 318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,000.00 |
| Dec 31, 2025 | 307,000.00 |
| Sep 30, 2025 | 296,000.00 |
| Mar 31, 2025 | 276,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 216,000.00 |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 184,000.00 |
| Sep 30, 2023 | 171,000.00 |
| Jun 30, 2023 | 157,000.00 |
| Mar 31, 2023 | 118,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 59,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 116,000.00 |
| Jun 30, 2021 | 111,000.00 |
| Mar 31, 2021 | 107,000.00 |